ReproCELL Incorporated
4978.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥18 | ¥16 | ¥14 | ¥10 |
| - Cash | ¥3 | ¥3 | ¥3 | ¥4 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥16 | ¥13 | ¥11 | ¥6 |
| Revenue | ¥0 | ¥0 | ¥1 | ¥1 |
| % Growth | 4.7% | -47.7% | 21.6% | – |
| Gross Profit | ¥0 | ¥0 | ¥1 | ¥0 |
| % Margin | 38.5% | 40.7% | 58.1% | 55.1% |
| EBITDA | -¥0 | -¥0 | ¥0 | -¥0 |
| % Margin | -32.9% | -60% | 10.2% | -3.1% |
| Net Income | -¥0 | -¥0 | ¥0 | ¥0 |
| % Margin | -36.5% | -64% | 14.8% | 9.8% |
| EPS Diluted | -1.92 | -3.21 | 1.42 | 0.78 |
| % Growth | 40.2% | -326.1% | 82.1% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |